Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002408313 | SCV002722660 | uncertain significance | Cardiovascular phenotype | 2019-03-07 | criteria provided, single submitter | clinical testing | The p.T635I variant (also known as c.1904C>T), located in coding exon 11 of the TTN gene, results from a C to T substitution at nucleotide position 1904. The threonine at codon 635 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and isoleucine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003491108 | SCV004237368 | uncertain significance | not provided | 2023-06-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003491108 | SCV005419520 | uncertain significance | not provided | 2024-05-30 | criteria provided, single submitter | clinical testing | Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |